Partial Neuronal Reprogramming via Modified Yamanaka Cocktail
Quality Report Card click to collapse
From Analysis:
Epigenetic reprogramming in aging neurons
Investigate mechanisms of epigenetic reprogramming in aging neurons, including DNA methylation changes, histone modification dynamics, chromatin remodeling, and partial reprogramming approaches (e.g., Yamanaka factors) to reverse age-related epigenetic alterations in post-mitotic neurons.
Hypotheses from Same Analysis (8)
These hypotheses emerged from the same multi-agent debate that produced this hypothesis.
Description
Mechanistic Overview
Partial Neuronal Reprogramming via Modified Yamanaka Cocktail starts from the claim that modulating OCT4 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "The hypothesis of partial neuronal reprogramming via a modified Yamanaka cocktail represents a paradigm shift in approaching neurodegeneration through epigenetic rejuvenation while preserving neuronal identity. This approach leverages the fundamental principle that cellular aging is largely driven by progressive epigenetic modifications rather than irreversible genetic damage, making it theoretically reversible through controlled reprogramming interventions....
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
graph TD
A["Aging Signals and Stress"]
B["Modified Yamanaka Cocktail (OCT4, SOX2, KLF4)"]
C["OCT4 Pioneer Transcription Factor"]
D["Chromatin Remodeling Complexes (SWI/SNF, NuRD)"]
E["Epigenetic Clock Reset"]
F["Neuronal Identity Preservation"]
G["Enhanced DNA Repair Mechanisms"]
H["Mitochondrial Biogenesis"]
I["Synaptic Plasticity Restoration"]
J["Neuroinflammation Reduction"]
K["Protein Aggregation Clearance"]
L["Cognitive Function Improvement"]
M["Neuroprotective Outcomes"]
N["Therapeutic Intervention Points"]
O["Risk Mitigation Strategies"]
A -->|"triggers"| B
B -->|"activates"| C
C -->|"recruits"| D
D -->|"facilitates"| E
C -->|"maintains"| F
E -->|"activates"| G
E -->|"enhances"| H
F -->|"preserves"| I
G -->|"reduces"| J
H -->|"improves"| I
J -->|"facilitates"| K
I -->|"leads to"| L
K -->|"contributes to"| L
L -->|"results in"| M
N -->|"modulates"| B
N -->|"implements"| O
classDef mechanism fill:#4fc3f7
classDef pathology fill:#ef5350
classDef therapy fill:#81c784
classDef outcome fill:#ffd54f
classDef genetics fill:#ce93d8
class A pathology
class B,C,D,E therapy
class F,G,H,I mechanism
class J,K pathology
class L,M outcome
class N,O therapy
3D Protein Structure (AlphaFold)
Open full viewerAlphaFold predicted structure available for Q01860
View AlphaFold StructureDimension Scores
Legacy Card View — expandable citation cards
✓ Supporting Evidence 17
Cyclic expression of Yamanaka factors ameliorates age-associated phenotypes in progeria mice without tumor for… MEDIUM▼
Aging is the major risk factor for many human diseases. In vitro studies have demonstrated that cellular reprogramming to pluripotency reverses cellular age, but alteration of the aging process through reprogramming has not been directly demonstrated in vivo. Here, we report that partial reprogramming by short-term cyclic expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) ameliorates cellular and physiological hallmarks of aging and prolongs lifespan in a mouse model of premature aging. Similarly, expression of OSKM in vivo improves recovery from metabolic disease and muscle injury in older wild-type mice. The amelioration of age-associated phenotypes by epigenetic remodeling during cellular reprogramming highlights the role of epigenetic dysregulation as a driver of mammalian aging. Establishing in vivo platforms to modulate age-associated epigenetic marks may provide further insights into the biology of aging.
Animal behaviours that are superficially similar can express different intents in different contexts, but how this flexibility is achieved at the level of neural circuits is not understood. For example, males of many species can exhibit mounting behaviour towards same- or opposite-sex conspecifics1, but it is unclear whether the intent and neural encoding of these behaviours are similar or different. Here we show that female- and male-directed mounting in male laboratory mice are distinguishable by the presence or absence of ultrasonic vocalizations (USVs)2-4, respectively. These and additional behavioural data suggest that most male-directed mounting is aggressive, although in rare cases it can be sexual. We investigated whether USV+ and USV- mounting use the same or distinct hypothalamic neural substrates. Micro-endoscopic imaging of neurons positive for oestrogen receptor 1 (ESR1) in either the medial preoptic area (MPOA) or the ventromedial hypothalamus, ventrolateral subdivision (
Factor-induced reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is inefficient, complicating mechanistic studies. Here, we examined defined intermediate cell populations poised to becoming iPSCs by genome-wide analyses. We show that induced pluripotency elicits two transcriptional waves, which are driven by c-Myc/Klf4 (first wave) and Oct4/Sox2/Klf4 (second wave). Cells that become refractory to reprogramming activate the first but fail to initiate the second transcriptional wave and can be rescued by elevated expression of all four factors. The establishment of bivalent domains occurs gradually after the first wave, whereas changes in DNA methylation take place after the second wave when cells acquire stable pluripotency. This integrative analysis allowed us to identify genes that act as roadblocks during reprogramming and surface markers that further enrich for cells prone to forming iPSCs. Collectively, our data offer new mechanistic insights into the natur
BACKGROUND: Accurately assessing individual ambient air pollution exposure is a crucial part of epidemiological studies looking at the adverse health effect of poor air quality. This is particularly challenging in developing countries with high levels of air pollution, mostly due to sparse monitoring networks with a lack of consistent data. METHODS: We evaluated the performance of six different machine learning algorithms in predicting fine particulate matter (PM2.5) concentrations in Ulaanbaatar, Mongolia using data between 2010 and 2018. We found that the algorithms produce robust results based on performance metrics. RESULTS: Random forest (RF) and gradient boosting models performed the best with leave-one-location-out cross-validated R2 of 0.82 for when using data from the entire study period. After applying tuned models on the hold-out test set, R2 increased to 0.96 for the RF and 0.90 for the gradient boosting model. We also predicted PM2.5 concentrations for each administrative
Ketogenic diets recapitulate certain metabolic aspects of dietary restriction such as reliance on fatty acid metabolism and production of ketone bodies. We investigated whether an isoprotein ketogenic diet (KD) might, like dietary restriction, affect longevity and healthspan in C57BL/6 male mice. We find that Cyclic KD, KD alternated weekly with the Control diet to prevent obesity, reduces midlife mortality but does not affect maximum lifespan. A non-ketogenic high-fat diet (HF) fed similarly may have an intermediate effect on mortality. Cyclic KD improves memory performance in old age, while modestly improving composite healthspan measures. Gene expression analysis identifies downregulation of insulin, protein synthesis, and fatty acid synthesis pathways as mechanisms common to KD and HF. However, upregulation of PPARα target genes is unique to KD, consistent across tissues, and preserved in old age. In all, we show that a non-obesogenic ketogenic diet improves survival, memory, and h
PD-1, a receptor expressed by T cells, B cells, and monocytes, is a potent regulator of immune responses and a promising therapeutic target. The structure and interactions of human PD-1 are, however, incompletely characterized. We present the solution nuclear magnetic resonance (NMR)-based structure of the human PD-1 extracellular region and detailed analyses of its interactions with its ligands, PD-L1 and PD-L2. PD-1 has typical immunoglobulin superfamily topology but differs at the edge of the GFCC' sheet, which is flexible and completely lacks a C" strand. Changes in PD-1 backbone NMR signals induced by ligand binding suggest that, whereas binding is centered on the GFCC' sheet, PD-1 is engaged by its two ligands differently and in ways incompletely explained by crystal structures of mouse PD-1 · ligand complexes. The affinities of these interactions and that of PD-L1 with the costimulatory protein B7-1, measured using surface plasmon resonance, are significantly weaker than expecte
Epigenetic modification of the mammalian genome by DNA methylation (5-methylcytosine) has a profound impact on chromatin structure, gene expression and maintenance of cellular identity. The recent demonstration that members of the Ten-eleven translocation (Tet) family of proteins can convert 5-methylcytosine to 5-hydroxymethylcytosine raised the possibility that Tet proteins are capable of establishing a distinct epigenetic state. We have recently demonstrated that Tet1 is specifically expressed in murine embryonic stem (ES) cells and is required for ES cell maintenance. Using chromatin immunoprecipitation coupled with high-throughput DNA sequencing, here we show in mouse ES cells that Tet1 is preferentially bound to CpG-rich sequences at promoters of both transcriptionally active and Polycomb-repressed genes. Despite an increase in levels of DNA methylation at many Tet1-binding sites, Tet1 depletion does not lead to downregulation of all the Tet1 targets. Interestingly, although Tet1-
Implementation of polygenic risk scores (PRS) may improve disease prevention and management but poses several challenges: the construction of clinically valid assays, interpretation for individual patients, and the development of clinical workflows and resources to support their use in patient care. For the ongoing Veterans Affairs Genomic Medicine at Veterans Affairs (GenoVA) Study we developed a clinical genotype array-based assay for six published PRS. We used data from 36,423 Mass General Brigham Biobank participants and adjustment for population structure to replicate known PRS-disease associations and published PRS thresholds for a disease odds ratio (OR) of 2 (ranging from 1.75 (95% CI: 1.57-1.95) for type 2 diabetes to 2.38 (95% CI: 2.07-2.73) for breast cancer). After confirming the high performance and robustness of the pipeline for use as a clinical assay for individual patients, we analyzed the first 227 prospective samples from the GenoVA Study and found that the frequency
Aging is a complex progression of changes best characterized as the chronic dysregulation of cellular processes leading to deteriorated tissue and organ function. Although aging cannot currently be prevented, its impact on life- and healthspan in the elderly can potentially be minimized by interventions that aim to return these cellular processes to optimal function. Recent studies have demonstrated that partial reprogramming using the Yamanaka factors (or a subset; OCT4, SOX2, and KLF4; OSK) can reverse age-related changes in vitro and in vivo. However, it is still unknown whether the Yamanaka factors (or a subset) are capable of extending the lifespan of aged wild-type (WT) mice. In this study, we show that systemically delivered adeno-associated viruses, encoding an inducible OSK system, in 124-week-old male mice extend the median remaining lifespan by 109% over WT controls and enhance several health parameters. Importantly, we observed a significant improvement in frailty scores in
Transcription factors (TFs) regulate gene expression through chromatin where nucleosomes restrict DNA access. To study how TFs bind nucleosome-occupied motifs, we focused on the reprogramming factors OCT4 and SOX2 in mouse embryonic stem cells. We determined TF engagement throughout a nucleosome at base-pair resolution in vitro, enabling structure determination by cryo-electron microscopy at two preferred positions. Depending on motif location, OCT4 and SOX2 differentially distort nucleosomal DNA. At one position, OCT4-SOX2 removes DNA from histone H2A and histone H3; however, at an inverted motif, the TFs only induce local DNA distortions. OCT4 uses one of its two DNA-binding domains to engage DNA in both structures, reading out a partial motif. These findings explain site-specific nucleosome engagement by the pluripotency factors OCT4 and SOX2, and they reveal how TFs distort nucleosomes to access chromatinized motifs.
Oct4, Sox2, Klf4, and cMyc (OSKM) reprogram somatic cells to pluripotency. To gain a mechanistic understanding of their function, we mapped OSKM-binding, stage-specific transcription factors (TFs), and chromatin states in discrete reprogramming stages and performed loss- and gain-of-function experiments. We found that OSK predominantly bind active somatic enhancers early in reprogramming and immediately initiate their inactivation genome-wide by inducing the redistribution of somatic TFs away from somatic enhancers to sites elsewhere engaged by OSK, recruiting Hdac1, and repressing the somatic TF Fra1. Pluripotency enhancer selection is a stepwise process that also begins early in reprogramming through collaborative binding of OSK at sites with high OSK-motif density. Most pluripotency enhancers are selected later in the process and require OS and other pluripotency TFs. Somatic and pluripotency TFs modulate reprogramming efficiency when overexpressed by altering OSK targeting, somatic
Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of agi… MEDIUM▼
Aging is a complex multifactorial process associated with epigenome dysregulation, increased cellular senescence, and decreased rejuvenation capacity. Short-term cyclic expression of octamer-binding transcription factor 4 (Oct4), sex-determining region Y-box 2 (Sox2), Kruppel-like factor 4 (Klf4), and cellular myelocytomatosis oncogene (cMyc) (OSKM) in wild-type mice improves health but fails to distinguish cell states, posing risks to healthy cells. Here, we delivered a single dose of adeno-associated viruses (AAVs) harboring OSK under the control of the cyclin-dependent kinase inhibitor 2a (Cdkn2a) promoter to specifically partially reprogram aged and stressed cells in a mouse model of Hutchinson-Gilford progeria syndrome (HGPS). Mice showed reduced expression of proinflammatory cytokines and extended life spans upon aged cell-specific OSK expression. The bone marrow and spleen, in particular, showed pronounced gene expression changes, and partial reprogramming in aged HGPS mice led
Engineered LINC MIR503HG-loaded extracellular vesicles maintain stemness and pluripotency during long-term hiP…▼
Development of a practical GMP-compliant manufacturing process for T cell-derived induced pluripotent stem cel…▼
Establishment of a human induced pluripotent stem cell line (BTHBIOi005-A) from a retinitis pigmentosa patient…▼
✗ Opposing Evidence 10
Recent studies have shown that defined sets of transcription factors can directly reprogram differentiated somatic cells to a different differentiated cell type without passing through a pluripotent state, but the restricted proliferative and lineage potential of the resulting cells limits the scope of their potential applications. Here we show that a combination of transcription factors (Brn4/Pou3f4, Sox2, Klf4, c-Myc, plus E47/Tcf3) induces mouse fibroblasts to directly acquire a neural stem cell identity-which we term as induced neural stem cells (iNSCs). Direct reprogramming of fibroblasts into iNSCs is a gradual process in which the donor transcriptional program is silenced over time. iNSCs exhibit cell morphology, gene expression, epigenetic features, differentiation potential, and self-renewing capacity, as well as in vitro and in vivo functionality similar to those of wild-type NSCs. We conclude that differentiated cells can be reprogrammed directly into specific somatic stem c
Using mouse skin, where bountiful reservoirs of synchronized hair follicle stem cells (HF-SCs) fuel cycles of regeneration, we explore how adult SCs remodel chromatin in response to activating cues. By profiling global mRNA and chromatin changes in quiescent and activated HF-SCs and their committed, transit-amplifying (TA) progeny, we show that polycomb-group (PcG)-mediated H3K27-trimethylation features prominently in HF-lineage progression by mechanisms distinct from embryonic-SCs. In HF-SCs, PcG represses nonskin lineages and HF differentiation. In TA progeny, nonskin regulators remain PcG-repressed, HF-SC regulators acquire H3K27me3-marks, and HF-lineage regulators lose them. Interestingly, genes poised in embryonic stem cells, active in HF-SCs, and PcG-repressed in TA progeny encode not only key transcription factors, but also signaling regulators. We document their importance in balancing HF-SC quiescence, underscoring the power of chromatin mapping in dissecting SC behavior. Our
The identification of distinct tissue-specific natural killer (NK) cell populations that apparently mature from local precursor populations has brought new insight into the diversity and developmental regulation of this important lymphoid subset. NK cells provide a necessary link between the early (innate) and late (adaptive) immune responses to infection. Gaining a better understanding of the processes that govern NK cell development should allow us to harness better NK cell functions in multiple clinical settings, as well as to gain further insight into how these cells undergo malignant transformation. In this review, we summarize recent advances in understanding sites and cellular stages of NK cell development in humans and mice.
Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells. We previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors. Here, we demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc. Human iPS cells were similar to human embryonic stem (ES) cells in morphology, proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity. Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas. These findings demonstrate that iPS cells can be generated from adult human fibroblasts.
Disruption of the nucleotide excision repair (NER) pathway by mutations can cause xeroderma pigmentosum, a syndrome predisposing affected individuals to development of skin cancer. The xeroderma pigmentosum C (XPC) protein is essential for initiating global genome NER by recognizing the DNA lesion and recruiting downstream factors. Here we show that inhibition of the deacetylase and longevity factor SIRT1 impairs global genome NER through suppressing the transcription of XPC in a SIRT1 deacetylase-dependent manner. SIRT1 enhances XPC expression by reducing AKT-dependent nuclear localization of the transcription repressor of XPC. Finally, we show that SIRT1 levels are significantly reduced in human skin tumors from Caucasian patients, a population at highest risk. These findings suggest that SIRT1 acts as a tumor suppressor through its role in DNA repair.
Alzheimer's disease (AD) is a devastating neurodegenerative disorder and a major medical problem. Here, we have investigated the impact of amyloid-β (Aβ) oligomers, AD-related neurotoxins, in the brains of rats and adult nonhuman primates (cynomolgus macaques). Soluble Aβ oligomers are known to accumulate in the brains of AD patients and correlate with disease-associated cognitive dysfunction. When injected into the lateral ventricle of rats and macaques, Aβ oligomers diffused into the brain and accumulated in several regions associated with memory and cognitive functions. Cardinal features of AD pathology, including synapse loss, tau hyperphosphorylation, astrocyte and microglial activation, were observed in regions of the macaque brain where Aβ oligomers were abundantly detected. Most importantly, oligomer injections induced AD-type neurofibrillary tangle formation in the macaque brain. These outcomes were specifically associated with Aβ oligomers, as fibrillar amyloid deposits were
Mutations in BRCA1 and BRCA2 predispose individuals to certain cancers1-3, and disease-specific screening and preventative strategies have reduced cancer mortality in affected patients4,5. These classical tumour-suppressor genes have tumorigenic effects associated with somatic biallelic inactivation, although haploinsufficiency may also promote the formation and progression of tumours6,7. Moreover, BRCA1/2-mutant tumours are often deficient in the repair of double-stranded DNA breaks by homologous recombination8-13, and consequently exhibit increased therapeutic sensitivity to platinum-containing therapy and inhibitors of poly-(ADP-ribose)-polymerase (PARP)14,15. However, the phenotypic and therapeutic relevance of mutations in BRCA1 or BRCA2 remains poorly defined in most cancer types. Here we show that in the 2.7% and 1.8% of patients with advanced-stage cancer and germline pathogenic or somatic loss-of-function alterations in BRCA1/2, respectively, selective pressure for biallelic i
Recent advances have suggested that direct induction of neural stem cells (NSCs) could provide an alternative to derivation from somatic tissues or pluripotent cells. Here we show direct derivation of stably expandable NSCs from mouse fibroblasts through a curtailed version of reprogramming to pluripotency. By constitutively inducing Sox2, Klf4, and c-Myc while strictly limiting Oct4 activity to the initial phase of reprogramming, we generated neurosphere-like colonies that could be expanded for more than 50 passages and do not depend on sustained expression of the reprogramming factors. These induced neural stem cells (iNSCs) uniformly display morphological and molecular features of NSCs, such as the expression of Nestin, Pax6, and Olig2, and have a genome-wide transcriptional profile similar to that of brain-derived NSCs. Moreover, iNSCs can differentiate into neurons, astrocytes, and oligodendrocytes. Our results demonstrate that functional NSCs can be generated from somatic cells b
iPSCs (induced pluripotent stem cells) offer an unparalleled opportunity to generate and study physiologically relevant cell types in culture. iPSCs can be generated by reprogramming almost any somatic cell type using pluripotency factors such as Oct4, SOX2, Nanog and Klf4. By reprogramming cells from patients carrying disease-associated mutations, and subsequent differentiation into the cell type of interest, researchers now have the opportunity to study disease-specific cell types which were previously inaccessible. In the case of PD (Parkinson's disease), reprogramming is advancing rapidly, and cell lines have been generated from patients carrying mutations in several disease-associated genes, including SNCA (α-synuclein), PARK2 (parkin), PINK1 (phosphatase and tensin homologue deleted on chromosome 10-induced putative kinase 1), PARK7 (DJ-1) and LRRK2 (leucine-rich repeat kinase 2), as well as idiopathic cases. Functional dopaminergic neurons have been differentiated from these cel
The Use of Stem Cell Differentiation Stage Factors (SCDSFs) Taken from Zebrafish Embryos during Organogenesis … MEDIUM▼
Studies conducted on Zebrafish embryos in our laboratory have allowed for the identification of precise moments of organogenesis in which a lot of genes are switched on and off, a sign that the genome is undergoing substantial changes in gene expression. Stem cell growth and differentiation stage-factors present in different moments of organogenesis have proven to have different specific functions in gene regulation. The substances present in the first stages of cell differentiation in Zebrafish embryos have demonstrated an ability to counteract the senescence of stem cells, reducing the expression of the beta-galactosidase marker, enhancing the genes Oct-4, Sox-2, c-Myc, TERT, and the transcription of Bmi-1, which act as key telomerase-independent repressors of cell aging. The molecules present in the intermediate to late stages of cell differentiation have proven to be able to reprogram pathological human cells, such as cancer cells and those of the basal layer of the epidermis in ps
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼
Perfect! Now I have sufficient evidence to generate novel therapeutic hypotheses. Let me create comprehensive, mechanistic hypotheses based on the current literature.
Based on the current research on epigenetic reprogramming in aging neurons, I'll generate novel therapeutic hypotheses that address key knowledge gaps and propose innovative mechanistic approaches:
Novel Therapeutic Hypotheses for Epigenetic Reprogramming in Aging Neurons
1. Temporal TET2-Mediated Hydroxymethylation Cycling
Description: Oscillating TET2 activation through small molecule modulators can restore dy🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼
Critical Evaluation of Therapeutic Hypotheses
Based on my analysis, here are the critical weaknesses and concerns for each hypothesis:
1. Temporal TET2-Mediated Hydroxymethylation Cycling
Specific Weaknesses:
- The hypothesis assumes TET2 can be selectively modulated in neurons without affecting other cell types, but TET2 is essential for hematopoietic stem cell function and immune regulation
- No evidence provided that oscillating TET2 activation is superior to sustained modulation
- The connection between circadian cycles and therapeutic efficacy is correlative, not causal
🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼
Practical Feasibility Assessment of Neuronal Epigenetic Reprogramming Hypotheses
Based on my analysis of the literature and drug development landscape, here's a comprehensive assessment of the practical feasibility for each therapeutic hypothesis:
1. Temporal TET2-Mediated Hydroxymethylation Cycling
Druggability Assessment: POOR
- Target Challenge: TET2 is notoriously difficult to drug directly. No selective small molecule modulators exist despite years of research
- Mechanism: Requires α-ketoglutarate, ascorbate, and Fe2+ as cofactors - makes selective modulation extremely
⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼
Price History
| Event | Price | Change | Source | Time | |
|---|---|---|---|---|---|
| 📄 | New Evidence | $0.418 | ▲ 2.1% | evidence_batch_update | 2026-04-13 02:18 |
| 📄 | New Evidence | $0.410 | ▲ 2.6% | evidence_batch_update | 2026-04-13 02:18 |
| ⚖ | Recalibrated | $0.399 | ▼ 1.8% | 2026-04-12 18:34 | |
| ⚖ | Recalibrated | $0.407 | ▼ 2.4% | 2026-04-12 10:15 | |
| ⚖ | Recalibrated | $0.417 | ▼ 2.5% | 2026-04-12 05:13 | |
| ⚖ | Recalibrated | $0.428 | ▼ 1.5% | 2026-04-10 15:58 | |
| ⚖ | Recalibrated | $0.434 | ▲ 1.7% | 2026-04-10 14:28 | |
| ⚖ | Recalibrated | $0.427 | ▼ 0.3% | 2026-04-08 18:39 | |
| ⚖ | Recalibrated | $0.428 | ▲ 3.4% | 2026-04-06 04:04 | |
| ⚖ | Recalibrated | $0.414 | ▼ 0.8% | 2026-04-04 16:38 | |
| ⚖ | Recalibrated | $0.417 | ▼ 1.7% | 2026-04-04 16:02 | |
| 📄 | New Evidence | $0.425 | ▲ 2.1% | evidence_batch_update | 2026-04-04 09:08 |
| ⚖ | Recalibrated | $0.416 | ▼ 6.7% | 2026-04-03 23:46 | |
| 📊 | Score Update | $0.446 | ▼ 37.0% | market_dynamics | 2026-04-03 03:08 |
| 💬 | Debate Round | $0.707 | ▲ 27.8% | market_dynamics | 2026-04-02 23:54 |
Clinical Trials (4) Relevance: 42%
Active
Completed
Total Enrolled
Highest Phase
📚 Cited Papers (54)
📓 Linked Notebooks (1)
Wiki Pages
KG Entities (47)
Dependency Graph (1 upstream, 0 downstream)
Linked Experiments (5)
Related Hypotheses
Estimated Development
🧪 Falsifiable Predictions (9)
Knowledge Subgraph (132 edges)
activates (1)
associated with (6)
▸ Show 1 more
co associated with (14)
co discussed (82)
▸ Show 77 more
implicated in (3)
investigated in (1)
involved in (6)
▸ Show 1 more
participates in (5)
promoted: Chromatin Accessibility Restoration via BRD4 Modulation (1)
promoted: Metabolic NAD+ Salvage Pathway Enhancement Through NAMPT Overexpression (1)
promoted: Nutrient-Sensing Epigenetic Circuit Reactivation (1)
promoted: Selective HDAC3 Inhibition with Cognitive Enhancement (1)
regulates (4)
therapeutic target (6)
▸ Show 1 more
Mechanism Pathway for OCT4
Molecular pathway showing key causal relationships underlying this hypothesis
graph TD
OCT4["OCT4"] -->|activates| cellular_reprogramming["cellular_reprogramming"]
OCT4_1["OCT4"] -->|therapeutic target| neurodegeneration["neurodegeneration"]
SIRT3["SIRT3"] -->|co discussed| OCT4_2["OCT4"]
BRD4["BRD4"] -->|co discussed| OCT4_3["OCT4"]
OCT4_4["OCT4"] -->|co discussed| BMAL1["BMAL1"]
OCT4_5["OCT4"] -->|co discussed| HDAC3["HDAC3"]
OCT4_6["OCT4"] -->|co discussed| SIRT1["SIRT1"]
OCT4_7["OCT4"] -->|co discussed| TET2["TET2"]
OCT4_8["OCT4"] -->|co discussed| SIRT3_9["SIRT3"]
OCT4_10["OCT4"] -->|co discussed| PGC1A["PGC1A"]
TET2_11["TET2"] -->|co discussed| OCT4_12["OCT4"]
HDAC3_13["HDAC3"] -->|co discussed| OCT4_14["OCT4"]
OCT4_15["OCT4"] -->|co discussed| BRD4_16["BRD4"]
PGC1A_17["PGC1A"] -->|co discussed| OCT4_18["OCT4"]
BRD4_19["BRD4"] -->|co associated with| OCT4_20["OCT4"]
style OCT4 fill:#ce93d8,stroke:#333,color:#000
style cellular_reprogramming fill:#81c784,stroke:#333,color:#000
style OCT4_1 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration fill:#ef5350,stroke:#333,color:#000
style SIRT3 fill:#ce93d8,stroke:#333,color:#000
style OCT4_2 fill:#ce93d8,stroke:#333,color:#000
style BRD4 fill:#ce93d8,stroke:#333,color:#000
style OCT4_3 fill:#ce93d8,stroke:#333,color:#000
style OCT4_4 fill:#ce93d8,stroke:#333,color:#000
style BMAL1 fill:#ce93d8,stroke:#333,color:#000
style OCT4_5 fill:#ce93d8,stroke:#333,color:#000
style HDAC3 fill:#ce93d8,stroke:#333,color:#000
style OCT4_6 fill:#ce93d8,stroke:#333,color:#000
style SIRT1 fill:#ce93d8,stroke:#333,color:#000
style OCT4_7 fill:#ce93d8,stroke:#333,color:#000
style TET2 fill:#ce93d8,stroke:#333,color:#000
style OCT4_8 fill:#ce93d8,stroke:#333,color:#000
style SIRT3_9 fill:#ce93d8,stroke:#333,color:#000
style OCT4_10 fill:#ce93d8,stroke:#333,color:#000
style PGC1A fill:#ce93d8,stroke:#333,color:#000
style TET2_11 fill:#ce93d8,stroke:#333,color:#000
style OCT4_12 fill:#ce93d8,stroke:#333,color:#000
style HDAC3_13 fill:#ce93d8,stroke:#333,color:#000
style OCT4_14 fill:#ce93d8,stroke:#333,color:#000
style OCT4_15 fill:#ce93d8,stroke:#333,color:#000
style BRD4_16 fill:#ce93d8,stroke:#333,color:#000
style PGC1A_17 fill:#ce93d8,stroke:#333,color:#000
style OCT4_18 fill:#ce93d8,stroke:#333,color:#000
style BRD4_19 fill:#ce93d8,stroke:#333,color:#000
style OCT4_20 fill:#ce93d8,stroke:#333,color:#000
3D Protein Structure
🧬 OCT4 — PDB 3L1P Click to expand 3D viewer
Source Analysis
Epigenetic reprogramming in aging neurons
neurodegeneration | 2026-04-04 | completed
Community Feedback
No comments yet. Be the first to comment!